Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H24N2O3 |
| Molecular Weight | 292.3734 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCC(=O)N2
InChI
InChIKey=LWAFSWPYPHEXKX-NSHDSACASA-N
InChI=1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20)/t11-/m0/s1
(S)-Carteolol is an enantiomer of the racemic drug carteolol, that is used to treat glaucoma. (S) isomer is a partial agonist with the high affinity to the beta-adrenoceptors. It was shown, that in the treatment of glaucoma, the therapeutic advantage of the R(+)-isomers is similar to the S(-)-isomers and there is no stereo-selectivity between the two enantiomers.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
0PE570TA5N
Created by
admin on Sat Dec 16 10:56:59 GMT 2023 , Edited by admin on Sat Dec 16 10:56:59 GMT 2023
|
PRIMARY | |||
|
6604410
Created by
admin on Sat Dec 16 10:56:59 GMT 2023 , Edited by admin on Sat Dec 16 10:56:59 GMT 2023
|
PRIMARY | |||
|
81102-77-4
Created by
admin on Sat Dec 16 10:56:59 GMT 2023 , Edited by admin on Sat Dec 16 10:56:59 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
